Search Results Search Sort by RelevanceMost Recent Policy Forum Jul 2016 Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad Jing Luo, MD and Aaron S. Kesselheim, MD, JD, MPH The Trans-Pacific Partnership Agreement could affect low-income patients’ access to medicines in signatory countries by reducing generic competition. AMA J Ethics. 2016;18(7):727-735. doi: 10.1001/journalofethics.2016.18.7.pfor1-1607. History of Medicine May 2019 Will We Code for Default ECMO? Daniel J. Brauner, MD and Christopher J. Zimmermann, MD CPR has become default treatment for all patients in cardiac arrest. The history of how this happened demonstrates the power of CPT coding. AMA J Ethics. 2019;21(5):E443-449. doi: 10.1001/amajethics.2019.443. Policy Forum May 2019 What Should We Learn From Early Hemodialysis Allocation About How We Should Be Using ECMO? Daniel Gutteridge, MD and Gabriel T. Bosslet, MD, MA Early hemodialysis allocation deliberations can inform deliberative democratic methods for setting criteria for and guiding policy making about ECMO. AMA J Ethics. 2019;21(5):E421-428. doi: 10.1001/amajethics.2019.421. Personal Narrative Jun 2019 One Resident’s Recommendations for Responding to Unjust Patient Bias Christian A. Pean, MD, MS and Dionne Hart, MD An orthopedic surgery physician’s experiences suggest strategies for addressing patients’ discriminatory behaviors or speech. AMA J Ethics. 2019;21(6):E530-535. doi: 10.1001/amajethics.2019.530. Personal Narrative Jun 2019 Health Risks of Practicing Correctional Medicine Dionne Hart, MD Correctional facilities’ physician employees are at risk for burnout, posttraumatic stress, and suicide. Prison reform should address needs of inmates and staff. AMA J Ethics. 2019;21(6):E540-545. doi: 10.1001/amajethics.2019.540. Letter to the Editor Oct 2019 Response to “Will We Code for Default ECMO?”: Clarifying the Scope of Do-Not-ECMO Orders Jacob A. Blythe, MA, Sarah E. Wieten, PhD, and Jason N. Batten, MD, MA The authors further consider the merits of preventing ECMO from becoming a default treatment. AMA J Ethics. 2019;21(10):E926-929. doi: 10.1001/amajethics.2019.926. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Medicine and Society Nov 2019 What Are Good Guidelines for Evaluating Uterus Transplantation? Margaret Horvat, MA and Ana Iltis, PhD Recent advances in UTx suggest it is on a trajectory toward becoming an accepted clinical practice to treat absolute uterine factor infertility. AMA J Ethics. 2019;21(11):E988-995. doi: 10.1001/amajethics.2019.988. Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996. Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974. Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page Next › Last page Last »
Policy Forum Jul 2016 Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad Jing Luo, MD and Aaron S. Kesselheim, MD, JD, MPH The Trans-Pacific Partnership Agreement could affect low-income patients’ access to medicines in signatory countries by reducing generic competition. AMA J Ethics. 2016;18(7):727-735. doi: 10.1001/journalofethics.2016.18.7.pfor1-1607.
History of Medicine May 2019 Will We Code for Default ECMO? Daniel J. Brauner, MD and Christopher J. Zimmermann, MD CPR has become default treatment for all patients in cardiac arrest. The history of how this happened demonstrates the power of CPT coding. AMA J Ethics. 2019;21(5):E443-449. doi: 10.1001/amajethics.2019.443.
Policy Forum May 2019 What Should We Learn From Early Hemodialysis Allocation About How We Should Be Using ECMO? Daniel Gutteridge, MD and Gabriel T. Bosslet, MD, MA Early hemodialysis allocation deliberations can inform deliberative democratic methods for setting criteria for and guiding policy making about ECMO. AMA J Ethics. 2019;21(5):E421-428. doi: 10.1001/amajethics.2019.421.
Personal Narrative Jun 2019 One Resident’s Recommendations for Responding to Unjust Patient Bias Christian A. Pean, MD, MS and Dionne Hart, MD An orthopedic surgery physician’s experiences suggest strategies for addressing patients’ discriminatory behaviors or speech. AMA J Ethics. 2019;21(6):E530-535. doi: 10.1001/amajethics.2019.530.
Personal Narrative Jun 2019 Health Risks of Practicing Correctional Medicine Dionne Hart, MD Correctional facilities’ physician employees are at risk for burnout, posttraumatic stress, and suicide. Prison reform should address needs of inmates and staff. AMA J Ethics. 2019;21(6):E540-545. doi: 10.1001/amajethics.2019.540.
Letter to the Editor Oct 2019 Response to “Will We Code for Default ECMO?”: Clarifying the Scope of Do-Not-ECMO Orders Jacob A. Blythe, MA, Sarah E. Wieten, PhD, and Jason N. Batten, MD, MA The authors further consider the merits of preventing ECMO from becoming a default treatment. AMA J Ethics. 2019;21(10):E926-929. doi: 10.1001/amajethics.2019.926.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Medicine and Society Nov 2019 What Are Good Guidelines for Evaluating Uterus Transplantation? Margaret Horvat, MA and Ana Iltis, PhD Recent advances in UTx suggest it is on a trajectory toward becoming an accepted clinical practice to treat absolute uterine factor infertility. AMA J Ethics. 2019;21(11):E988-995. doi: 10.1001/amajethics.2019.988.
Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996.
Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974.